SG11202103567RA - Methods of treatment of inflammatory conditions and associated infections - Google Patents

Methods of treatment of inflammatory conditions and associated infections

Info

Publication number
SG11202103567RA
SG11202103567RA SG11202103567RA SG11202103567RA SG11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA
Authority
SG
Singapore
Prior art keywords
treatment
methods
inflammatory conditions
associated infections
infections
Prior art date
Application number
SG11202103567RA
Inventor
Wayne Finlayson
Original Assignee
Servatus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018903823A external-priority patent/AU2018903823A0/en
Application filed by Servatus Ltd filed Critical Servatus Ltd
Publication of SG11202103567RA publication Critical patent/SG11202103567RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202103567RA 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections SG11202103567RA (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2018903823A AU2018903823A0 (en) 2018-10-10 Compositions and methods of treatment of conditions of the gastrointestinal tract
AU2018903822A AU2018903822A0 (en) 2018-10-10 Compositions and methods of treatment of inflammatory conditions and infections
AU2019901176A AU2019901176A0 (en) 2019-04-05 Compositions and methods of treatment of inflammatory conditions and associated infections
AU2019901175A AU2019901175A0 (en) 2019-04-05 Compositions and methods of treatment of conditions of the gastrointestinal tract
PCT/AU2019/051092 WO2020073088A1 (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Publications (1)

Publication Number Publication Date
SG11202103567RA true SG11202103567RA (en) 2021-05-28

Family

ID=70163621

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103567RA SG11202103567RA (en) 2018-10-10 2019-10-10 Methods of treatment of inflammatory conditions and associated infections

Country Status (8)

Country Link
US (1) US20210338749A1 (en)
EP (1) EP3863656A4 (en)
JP (1) JP2022504792A (en)
CN (1) CN114206362A (en)
AU (1) AU2019356524A1 (en)
CA (1) CA3124725A1 (en)
SG (1) SG11202103567RA (en)
WO (1) WO2020073088A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022115907A1 (en) * 2020-12-01 2022-06-09 Servatus Ltd Methods for improving sleep quality
JP2023553956A (en) * 2020-12-09 2023-12-26 セルバトゥス リミテッド Combination therapy for inflammatory disorders of the joints
CA3225609A1 (en) * 2021-08-19 2023-02-23 Societe Des Produits Nestle S.A. Postbiotic
WO2023021140A1 (en) * 2021-08-19 2023-02-23 Société des Produits Nestlé S.A. Postbiotic
US20230141346A1 (en) * 2021-11-05 2023-05-11 Trillium Medical Products, LLC Infused undergarment
WO2023097375A1 (en) * 2021-12-02 2023-06-08 Servatus Ltd Methods for the treatment of constipation
CN115725469B (en) * 2022-11-28 2024-05-14 广西大学 Lactobacillus paracasei and application thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306716B1 (en) * 1999-06-21 2001-10-02 Mendes S U R L ASSOCIATION OF LACTIC BACTERIA AND ITS USE FOR THE PREVENTION AND / OR THERAPEUTIC TREATMENT OF INFECTIONS AND INFLAMMATORY STATES.
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
ITMI20032391A1 (en) * 2003-12-05 2005-06-06 Consiglio Nazionale Ricerche MENSA OLIVES CONTAINING PROBIOTIC MICRO-ORGANISMS.
KR20150003908A (en) * 2007-07-03 2015-01-09 다누타 크루셰프스카 Applications of alpha-ketoglutarate for manufacturing organic biofuel
JP4876262B2 (en) * 2008-10-24 2012-02-15 防衛省技術研究本部長 Novel plant lactic acid strain having anti-inflammatory effect, preventive and therapeutic agent, inhibitor and additive for inflammatory bowel disease or chronic diarrhea using the strain
AU2010339573B2 (en) * 2009-12-31 2014-08-28 Ira Milton Trachtman Compositions and method for treatment and prophylaxis of inflammatory bowel disease
US9492487B2 (en) * 2010-02-01 2016-11-15 Matthew Ryan Garner Microbial product containing multiple microorganisms
CA2833937C (en) * 2011-05-16 2022-04-05 Organobalance Medical Ag Lactobacillus strains, compositions containing them and use of the strains to prevent or treat conditions caused by streptococcus pyogenes
CN105517557B (en) * 2013-04-23 2021-11-30 特雷根控股有限公司 Bacterial strains having antimicrobial activity and biocontrol compositions comprising said strains
ITMI20130793A1 (en) * 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES.
KR20150023132A (en) * 2013-08-23 2015-03-05 (주) 아이투비 Composit for improving atopic dermatitis
CN104000184A (en) * 2013-12-09 2014-08-27 胡安然 Food for alleviating atrophic gastritis
WO2016179639A1 (en) * 2015-05-13 2016-11-17 Markson Ro Probiotic compositions and uses thereof
CN106860441B (en) * 2017-02-10 2019-12-31 中国医学科学院医药生物技术研究所 Application of 4-oxo-2-butenamide derivative in preparation of bacteriostatic agent
KR101917497B1 (en) * 2017-02-18 2018-11-09 박병희 Novel Lactobacillus buchneri and Use thereof
TWI607758B (en) * 2017-03-07 2017-12-11 景岳生物科技股份有限公司 Lactobacillus paracasei strain gmnl-653 and composition having the same for improving psoriasis symptoms
SG11201908857QA (en) * 2017-04-11 2019-10-30 Servatus Ltd Methods for the treatment of inflammation and inflammatory conditions
US11406672B2 (en) * 2018-03-14 2022-08-09 Sustainable Community Development, Llc Probiotic composition and feed additive

Also Published As

Publication number Publication date
CA3124725A1 (en) 2020-04-16
AU2019356524A1 (en) 2021-05-13
WO2020073088A1 (en) 2020-04-16
US20210338749A1 (en) 2021-11-04
JP2022504792A (en) 2022-01-13
EP3863656A1 (en) 2021-08-18
CN114206362A (en) 2022-03-18
EP3863656A4 (en) 2022-06-29

Similar Documents

Publication Publication Date Title
SG11202103567RA (en) Methods of treatment of inflammatory conditions and associated infections
EP3609515A4 (en) Methods for the treatment of inflammation and inflammatory conditions
IL281277A (en) Compositions and methods for the treatment of viral infections
ZA201801266B (en) Composition and method for treatment and prophylaxis of intestinal infection and inflammation
GB201804514D0 (en) Treatment of pyroptosis
EP3503903A4 (en) Ascaroside treatment of autoimmune and inflammatory diseases
IL272937A (en) Compositions and methods for the treatment of fibrotic diseases
GB201804515D0 (en) Treatment of necroptosis
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
IL281775A (en) Methods of treatment of infections using bacteria
IL276053A (en) Therapeutic-gard and method of use thereof
IL260987A (en) Treatment and diagnosis of inflammatory disorders
PT3708174T (en) Methods and treatment of trauma
SG11202003009QA (en) Methods of treating bacterial infections
GB201810923D0 (en) Compositions and method of treatment
EP3606516A4 (en) Method of treating and preventing infections
AU2018903822A0 (en) Compositions and methods of treatment of inflammatory conditions and infections
GB201815000D0 (en) Treatment of hypothroidism and related conditions
EP4003283C0 (en) Treatment of inflammatory skin conditions
AU2019901176A0 (en) Compositions and methods of treatment of inflammatory conditions and associated infections
HUE064198T2 (en) Treatment of pneumonia
GB201816914D0 (en) Treatment of inflammation
GB201810925D0 (en) Compositions and methods of treatment
AU2017902271A0 (en) Methods for the treatment of inflammation and inflammatory conditions
EP3773328C0 (en) Poland syndrome and methods of treatment